Zacks Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-17,462
| Closed | -$2.48M | – | 528 |
|
|
2019
Q2 | $2.48M | Sell |
17,462
-43
| -0.2% | -$6.1K | 0.05% | 229 |
|
|
2019
Q1 | $2.54M | Sell |
17,505
-1,683
| -9% | -$244K | 0.05% | 220 |
|
|
2018
Q4 | $2.17M | Buy |
19,188
+601
| +3% | +$68K | 0.05% | 221 |
|
|
2018
Q3 | $2.5M | Buy |
18,587
+975
| +6% | +$131K | 0.05% | 238 |
|
|
2018
Q2 | $1.98M | Buy |
17,612
+1,037
| +6% | +$116K | 0.04% | 278 |
|
|
2018
Q1 | $1.77M | Buy |
16,575
+1,448
| +10% | +$155K | 0.04% | 289 |
|
|
2017
Q4 | $1.66M | Buy |
15,127
+298
| +2% | +$32.6K | 0.04% | 306 |
|
|
2017
Q3 | $1.6M | Buy |
14,829
+1,736
| +13% | +$188K | 0.04% | 284 |
|
|
2017
Q2 | $1.32M | Buy |
13,093
+473
| +4% | +$47.8K | 0.03% | 304 |
|
|
2017
Q1 | $1.14M | Buy |
12,620
+858
| +7% | +$77.2K | 0.03% | 325 |
|
|
2016
Q4 | $896K | Buy |
11,762
+9
| +0.1% | +$686 | 0.03% | 345 |
|
|
2016
Q3 | $980K | Buy |
11,753
+309
| +3% | +$25.8K | 0.03% | 332 |
|
|
2016
Q2 | $943K | Sell |
11,444
-2,811
| -20% | -$232K | 0.03% | 335 |
|
|
2016
Q1 | $1.08M | Buy |
+14,255
| New | +$1.08M | 0.03% | 306 |
|
|
2015
Q1 | – | Sell |
-3,972
| Closed | -$253K | – | 637 |
|
|
2014
Q4 | $253K | Buy |
+3,972
| New | +$253K | 0.01% | 541 |
|